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Objectives: To analyze the effects of feeding Helianthus tuberosus (HT) tubers on
glucose tolerance and lipid profile in rats fed a high-fat diet (HFD).
Methods: A normal HFD or HFD including 10 w/w% HT tubers (HFD + HT) was fed to
F334/Jcl rats. After 10 weeks, organ weights, glucose tolerance, and lipid profile were
analyzed.
Results: The body weight, liver weight, and epidermal fat content in the HFD group
were higher than those of the normal group, and similar to those of the HFD + HT group.
The oral glucose tolerance test at 10 weeks revealed that the blood glucose level 30 min
after beginning the test in the HFD + HT group was significantly lower than that in the
HFD group. Liver triglyceride and total cholesterol levels in the HFD + HT group were
significantly lower than those in the HFD group. Fecal triglyceride and total cholesterol
levels in the HFD + HT group were higher than those in the HFD group. Histological
analyses revealed that fat and glycogen accumulation increased in the HFD group, but
decreased in the HFD + HT group.
Conclusions: These results indicate that HT tubers have anti-fatty liver effects based on
improvements in glucose tolerance and the hepatic lipid profile.1. Introduction
Non-alcoholic fatty liver disease (NAFLD) is a recognized
condition that may progress to end-stage liver disease [1].
Previous studies have shown that 10%–40% of patients with
NAFLD develop non-alcoholic steatohepatitis (NASH) [2].
Because NAFLD and NASH are risk factors for liver cancer,
preventing their progression is important [3]. The progression
of NAFLD and NASH is associated with type 2 diabetes
mellitus and hyperlipidemia [4,5]. Therefore, preventing
hyperlipidemia and changes in glucose tolerance is necessary
to limit the progression of NAFLD and NASH.Hyperlipidemia and type 2 diabetes mellitus are induced by
excess intake of high-calorie and high-fat diets [6,7]. One way to
prevent the progression of hyperlipidemia and type 2 diabetes
mellitus is to refrain from ingesting such diets. However,
maintaining a restricted diet is difficult for many people, and
compliance with this restriction is poor. Alternatively,
hyperlipidemia and type 2 diabetes mellitus can be prevented
or treated with drugs or by consuming functional foods that
have anti-hyperlipidemia or anti-type 2 diabetes mellitus ef-
fects. Of these options, functional foods have high safety and
can be used as part of a normal diet. Therefore, functional foods
that improve hyperlipidemia and glucose tolerance may be
useful candidates for preventing the progression of NAFLD and
NASH. However, such functional foods have not been reported.
Helianthus tuberosus (HT, Jerusalem artichoke) is a perennial
plant whose tubers are used as a food worldwide; it grows well in
the semi-arid tropics. HT tubers contain inulin, a non-degradable
oligosaccharide polymer comprising 30–35 fructose units that
are linearly arranged in b-1,2 linkages with an a-1,2-linked D-rticle under the CC BY-NC-ND license (http://
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that inulin improved glucose tolerance and liver lipid profile in
rats fed a high-fat diet (HFD) [11,12]. Based on this background
information, we hypothesized that feeding HT tubers might
improve the hyperglycemia or hyperlipidemia induced by an
HFD, suggesting their potential as a useful functional food for
preventing the progression of NAFLD and NASH. In the current
study, rats fed an HFD were used to assess the effect of feeding
HT tubers on glucose tolerance and the hepatic lipid profile.
2. Materials and methods
2.1. Animals and diets
Four-week-old F344/Jcl rats were purchased from CLEA
(Tokyo, Japan). The rats were acclimated for one week before
use. The animals were cared for according to approved pro-
cedures, and the experiments received institutional animal
approval (approval number: 13137). Normal diets and HFDs
were purchased from the Oriental Yeast Company (Tokyo,
Japan). Components of the HFD were milk casein (256 g/kg), L-
cystine (3.6 g/kg), maltodextrin (60 g/kg), a-cornstarch (160 g/
kg), sucrose (55 g/kg), soybean oil (20 g/kg), lard (330 g/kg),
cellulose (66.1 g/kg), calcium carbonate (1.8 g/kg), and choline
bitartrate (2.5 g/kg). HT tuber powder was provided by the
Tokushima Prefectural Government. HT tuber components were
carbohydrates (325 g/kg), inulin (452 g/kg), protein (92 g/kg),
ash (68 g/kg), water (54 g/kg), and fat (9 g/kg). The HFD + HT
diet was prepared by mixing the HFD diet with HT tuber
powder. The final concentration of HT powder was 10% (w/w).
The basic composition of each diet is as follows, normal diet;
carbohydrate: 553 g/kg, protein: 231 g/kg, fat: 51 g/kg, HFD
diet; carbohydrate: 248 g/kg, protein: 230 g/kg, fat: 350 g/kg,
HFD + HT diet; carbohydrate: 256 g/kg, protein: 216 g/kg, fat:
316 g/kg, inulin: 45 g/kg. Rats ingested each diet and water
freely. Eight rats were included in each group.
2.2. Measurements of body and organ tissue weights
Body weight in each group was measured weekly for 10
weeks. After 10 weeks, urethane (2.5 g/kg) was administered
intraperitoneally and liver and epididymal fat were sampled and
weighed. These samples were stored at −80 C before use. Slices
of the liver were preserved in formalin for histological analyses.
Caloric intake was calculated by measuring the total feed
consumed by each group.
2.3. Plasma glucose level measurements and oral
glucose tolerance test (OGTT)
After 10 weeks, blood glucose was measured in each group
of rats using blood drawn from the tail vein after 16 h of fasting.
The OGTT was performed by administering 1 g/kg glucose to
each rat and harvesting blood samples from the tail vein inter-
mittently. After centrifugation (2000 ×g, 10 min), blood glucose
was measured in the serum. The blood glucose measurement kit
was purchased from Sanwa Kagaku (Aichi, Japan). The mea-
surements were performed according to the manual provided by
the manufacturer.2.4. Plasma aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) measurement
Blood samples used for fasting glucose measurements were
also used for measurement of serum AST and ALT levels. AST
color endpoint assay kit and ALT color endpoint assay kit were
purchased from Empire Genomics (Buffalo, NY, USA). Mea-
surements were performed according to the manual provided by
the manufacturer.
2.5. Lipid profile analyses
Blood samples used for fasting glucose measurements were
also used for measurement of serum triglyceride (TG) and total
cholesterol (TC) levels. Total lipids of liver tissue and feces
between 8 and 9 weeks of feeding were extracted by the Folch
method [13]. Briefly, liver tissue and feces were homogenized in
phosphate buffer. Folch solution (chloroform/methanol: 2/1)
was added to this lysate and vortexed. These samples were
centrifuged at 1500 ×g, for 15 min and the lower layer was
collected. Sodium chloride solution (0.5%) was added and
centrifuged at 1500 ×g for 15 min. The lower layer was
collected and concentrated using a rotation evaporator. The
obtained lipids were dissolved in 2-propanol and used for
measurement of TC and TG. TC and TG measurement kits
were purchased from Wako (Osaka, Japan). Measurements
were performed according to the manual provided by the
manufacturer.
2.6. Histological analyses
Liver tissues were embedded in paraffin and cut into sections
(4 mm thick). Sections were stained with hematoxylin and eosin
(H&E) or 1% periodic acid-Schiff's (PAS) solution as described
previously [14].
2.7. Statistical analyses
Results are shown as the mean ± SD. Data were subjected to
a one-way analysis of variance and differences between groups
were determined using the Holm's sequential Bonferroni pro-
cedure. All analyses were performed using Microsoft Excel
(Redford, WA, USA). All P-values were two-sided. Differences
with P < 0.05 were considered significant.
3. Results
3.1. Changes in body and organ tissue weights
The average body weight of rats in the HFD group was
significantly higher than that in the normal diet group from 3 to
10 weeks, but the same as that in the HFD + HT group
throughout the experiment (Figure 1). Caloric intake was iden-
tical between the HFD and HFD + HT groups (Table 1). The
liver and epididymal fat weights of rats in the HFD group were
higher than those of the normal group rats, but identical to those
of the HFD + HT group rats (Table 1). These data indicated that
intake of HT tubers did not affect the changes in body and organ
tissue weights induced by the HFD.
Figure 1. Changes of body weighs in each dietary treatment group.
Body weights of rats fed a normal diet (B), HFD (▫), or HFD + HT (:).
*P < 0.05 compared with control. Data are expressed as means ± SD. n = 8.
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ALT level
The fasting blood glucose level of rats in the HFD group was
higher at 10 weeks than that of the normal group. Importantly,
the fasting blood glucose level of rats in the HFD + HT group
decreased compared to that in the HFD group (Table 1). The
OGTT showed a significant but transient increase of blood
glucose in the HFD group compared to that in the normal group
(Figure 2). In contrast, the blood glucose level 30 min after the
OGTT in the HFD + HT group decreased significantly compared
to that in the HFD group. These data indicate that intake of HT
tubers inhibited the transient increase in blood glucose induced
by an acute glucose load. However, the plasma AST and ALT
levels at 10 weeks were not different among the groups
(Table 1).
3.3. Effect on lipid profiles in blood, liver, and faeces
Blood TG and TC levels were similar among the three
treatment groups (Table 1). However, liver TG and TC levels in
the HFD group increased compared to those in the normal diet
group. The liver TG level of the HFD + HT group decreased
significantly compared to that in the HFD group. Fecal TG and
TC levels in the HFD group significantly increased compared to
those in the normal group, and the levels in the HFD + HT group
significantly increased compared to those in the HFD group.
These data indicate that the intake of HT tubers decreased liver
TG and TC content and significantly increased the content of
fecal TG and TC.
3.4. Histopathological analyses of hepatocytes
H&E and PAS-stained hepatic sections are shown in
Figure 3. Accumulation of fat and glycogen was observed in the
Figure 2. The effect of Heliantus tuberosus tubers (HT) on blood glucose
levels after OGTT.
Blood glucose levels after OGTT in the normal (B), HFD (▫), and
HFD + HT (:) groups. *P < 0.05 compared with HFD. Data are expressed
as means ± SD. n = 8. HFD: high-fat diet.
Figure 3. Histopathological analyses of liver sections.
HFD, high-fat diet; HT, Heliantus tuberosus tubers; H&E, hematoxylin and
eosin; PAS: Periodic acid-Schiff.
Naoto Okada et al./Asian Pacific Journal of Tropical Medicine 2017; 10(5): 439–443442liver of rats fed an HFD diet, but not in the liver of rats fed a
normal diet. Slight accumulation of fat and glycogen was
observed in the livers of HFD + HT rats, although this accu-
mulation was weaker than that in the HFD group. These data
indicate that the HFD induced accumulation of fat and glycogen
in the liver and that this accumulation was inhibited by intake of
HT tubers.
4. Discussion
The results of this study indicate that intake of HT tubers
increased the excretion of TG and TC into the feces and
decreased TG and TC levels in the liver. Moreover, the OGTT
showed that intake of HT tubers improved glucose tolerance.
Histological studies indicated that intake of HT tubers inhibited
the accumulation of fat and glycogen in the liver.
We speculate that the positive effect of HT tubers on lipid
profile and glucose tolerance can be attributed to their inulin
content. Inulin is a water-soluble dietary fiber that has anti-
metabolic syndrome effects. It can affect serum glucose and
lipid levels by delaying gastric emptying or modifying thesecretion of gut hormones such as glucagon-like peptide 1 [12].
Previous studies showed that inulin inhibited absorption of TG
and TC via increased excretion of TG and TC to the feces [9–
11]. In our study, the amount of TG and TC in the liver of rats
in the HFD + HT group was less than that reported for the
HFD group. Moreover, the fecal amount of TG and TC in the
HFD + HT group was higher than that of the HFD group.
These results indicate that the inulin in HT tubers facilitated
the excretion of TG and TC to the feces.
In this study, the amount of food intake in the HFD + HT
group was approximately (5–10) g/day. This consumption was
equivalent to (0.25–0.50) g/day of inulin intake. Because the
average body weight of rats in the HFD + HT group during the
test was approximately 200 g, the inulin intake was (1.25–2.50)
g/kg/day. Based on the conversion formula of the US FDA ac-
cording to body surface area, the human-equivalent dose of
inulin for which this HT effect was reported in our study was
approximately (0.2–0.4) g/kg/day (BW; for 60 kg adult body
weight; conversion coefficient: 6.2) [15]. Inulin has been reported
to cause gastrointestinal problems, and this adverse effect
occurred with inulin intake over 30 g/day in a human study
[15]. The inulin dose in our study was lower than that at which
adverse effects have been reported to develop. Moreover,
loose stools were not observed in the HFD + HT group (data
not shown). These results indicate that gastrointestinal
problems induced by HT intake did not occur in our study.
HT tubers are used as food worldwide and their safety is well
established. Therefore, we may be able to obtain the effects
observed in our rat study in humans using the conventional
intake of HT tubers.
The current results indicate that intake of HT tubers inhibited
the accumulation of fat and glycogen in the liver. Previous
histological studies demonstrated the accumulation of excess fat
and glycogen in the liver of NAFLD or NASH patients [16].
Because the progression of NAFLD and NASH is related to
the presence of type 2 diabetes mellitus and hyperlipidemia,
improvement of the lipid profile and glucose tolerance by
feeding HT tubers might inhibit fatty liver changes such as
NAFLD or NASH. However, HT intake did not decrease the
plasma AST and ALT levels in our study. This indicates that
HT suppressed fatty liver degeneration, but may not suppress
liver damage. In fact, Zaky et al. reported that HT tubers
decreased fasting blood glucose level, but did not decrease
plasma AST and ALT level in a diabetic rat model [17].
Overall, this is the first report describing the possibility of HT
tubers inhibiting the progression of fatty liver disease.
Water-soluble dietary fibers, such as inulin, can modify
levels of short-chain fatty acids (SCFAs) that are produced from
colonic fermentation of prebiotics and change the gut micro-
biome [18]. Takemura et al. reported that inulin prolongs the
survival of probiotics in mice fed an HFD [19]. We speculated
that HT may change the gut microbiome in our study;
however, the details were unclear. Inulin also promotes the
production of SCFAs such as propionate or butyrate [20].
SCFAs have an inhibitory effect on the production of
inflammatory cytokines [18]. Because the induction of an
inflammatory response is involved in exacerbating aberrant
glucose tolerance and fatty liver, the anti-inflammatory effect
of SCFAs may also be involved in the suppression of inflam-
mation by HT tubers. A previous study showed that inulin
increased SCFA production and improved liver lipid metabolism
Naoto Okada et al./Asian Pacific Journal of Tropical Medicine 2017; 10(5): 439–443 443[21]. It is necessary to analyze the correlation between changes in
the gut microbiome and SCFA content, fatty liver degeneration,
and impaired glucose tolerance.
In NAFLD and NASH patients, levels of oxidative stress
markers are increased in the liver [22]. Wang et al. reported that
Monordica charantia, which improved the liver lipid profile,
decreased oxidative stress in the liver induced by a HFD [23].
Inhibition of fatty liver changes by HT tubers may also
decrease oxidative stress in the liver. Expression of fatty acid
synthase is associated with accumulation of fat in the liver [24].
Future studies should investigate changes in the expression of
genes involved in fatty acid synthesis. Moreover, analyses of
the detailed mechanism by which glucose tolerance is
improved by HT tubers should also be performed using
measurements of serum insulin content or HOMA-R index [25].
A previous study reported that inulin did not inhibit the in-
crease of body weight in rats fed a normal diet [26]. Therefore,
we did not assess the effects of HT on weight gain in rats fed
a normal diet. Plasma TG and TC levels did not increase in
the HFD group. Because weight gain and increased
epididymal fat mass were observed in the HFD group, an
appropriate HFD load could be determined. Analyses using
rats fed an HFD for a prolonged period may be required to
determine the effect of HT tubers on plasma TG and TC
contents.
In our study, feeding rats an HFD containing HT tubers
decreased the TG and TC contents in the liver induced excretion
of TG and TC into the feces, improved glucose tolerance, and
inhibited the accumulation of fat and glycogen compared to that
in rats fed the HFD without HT tubers. Although further ana-
lyses are needed to confirm our results, these results indicate that
HT tubers have the ability to improve glucose tolerance and
hepatic lipid profile, and may be a useful functional food to
prevent the progression of fatty liver to NAFLD or NASH.
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